To prove clinical relevance of the USP10‐POLR2A‐SLC7A11 axis, we finally assessed POLR2A and SLC7A11 proteins in HNSCC samples via immunohistochemistry (Figure S8A,B, Supporting Information). This evidence concerns the gene USP10 and head and neck squamous cell carcinoma.